Subscribe
Menu
Login
Search
Login
Subscribe
News & Opinion
Publications
AN INTERACTIVE EXPERIENCE
Current Issue
June 2022, Issue 2
Preview This Issue
Archives
Features
Quarterly Magazine
Current Issue
Summer 2022
Preview This Issue
Archives
Features
Categories
Biochemistry
Cancer
Cell Biology
Community
Drug Development
Environment
Evolution
Genetics
Immunology
Microbiology
Neuroscience
Physiology
Public Health
Zoology
Multimedia
Crossword Puzzles
Infographics
Science Snapshot
Words for Nerds
Videos
Webinars
Research Resources
Podcasts
Events
Infographics
eBooks
Videos
The Scientist University
Research Products Blog
Articles
Home
Subjects
generics
generics
Teva Buys Allergan Generics for $40.5 Billion
Tracy Vence | Jul 27, 2015
Meanwhile, Allergan acquires drug developer Naurex in a $560 million deal.
Endo to Pay $8 Billion for Par
Bob Grant | May 19, 2015
The deal would create one of the five biggest generic drugmakers in the U.S.
Drugmaker Teva Bids $40 Billion for Mylan
Bob Grant | Apr 23, 2015
The Israel-based pharmaceutical company makes an unsolicited offer for a smaller, Netherlands-based rival as its main product faces competition from generics.
Opinion: Parachuting off the Patent Cliff
Sandra S. Lee | Dec 6, 2012
As the United States edges ever closer to the dreaded fiscal cliff, the pharmaceutical industry approaches a precipice of its own.